BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16522147)

  • 1. Animal carcinogenicity studies: 1. Poor human predictivity.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Feb; 34(1):19-27. PubMed ID: 16522147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal carcinogenicity studies: 2. Obstacles to extrapolation of data to humans.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Feb; 34(1):29-38. PubMed ID: 16522148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editor's Highlight: Negative Predictors of Carcinogenicity for Environmental Chemicals.
    Hill T; Nelms MD; Edwards SW; Martin M; Judson R; Corton JC; Wood CE
    Toxicol Sci; 2017 Jan; 155(1):157-169. PubMed ID: 27679563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended Analysis and Evidence Integration of Chloroprene as a Human Carcinogen.
    Sax SN; Gentry PR; Van Landingham C; Clewell HJ; Mundt KA
    Risk Anal; 2020 Feb; 40(2):294-318. PubMed ID: 31524302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to cancer assessment in EPA's Integrated Risk Information System.
    Gehlhaus MW; Gift JS; Hogan KA; Kopylev L; Schlosser PM; Kadry AR
    Toxicol Appl Pharmacol; 2011 Jul; 254(2):170-80. PubMed ID: 21034767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenic risk of emerging persistent organic pollutant perfluorooctane sulfonate (PFOS): A proposal of classification.
    Arrieta-Cortes R; Farias P; Hoyo-Vadillo C; Kleiche-Dray M
    Regul Toxicol Pharmacol; 2017 Feb; 83():66-80. PubMed ID: 27871870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of potential carcinogenicity of organic chemicals in synthetic turf crumb rubber.
    Perkins AN; Inayat-Hussain SH; Deziel NC; Johnson CH; Ferguson SS; Garcia-Milian R; Thompson DC; Vasiliou V
    Environ Res; 2019 Feb; 169():163-172. PubMed ID: 30458352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop.
    Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic assessment of carcinogenicity of chemicals in hydraulic-fracturing fluids and flowback water.
    Xu X; Zhang X; Carrillo G; Zhong Y; Kan H; Zhang B
    Environ Pollut; 2019 Aug; 251():128-136. PubMed ID: 31075693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency.
    Wang NC; Venkatapathy R; Bruce RM; Moudgal C
    Regul Toxicol Pharmacol; 2011 Mar; 59(2):215-26. PubMed ID: 20951756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of carcinogen hazard characterisation based on animal studies and epidemiology.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):66-70. PubMed ID: 15667598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US EPA's IRIS pilot program: establishing IRIS as a centralized, peer-reviewed data base with agency consensus. Integrated Risk Information System.
    Mills A; Foureman GL
    Toxicology; 1998 May; 127(1-3):85-95. PubMed ID: 9699796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.
    Kleinstreuer NC; Dix DJ; Houck KA; Kavlock RJ; Knudsen TB; Martin MT; Paul KB; Reif DM; Crofton KM; Hamilton K; Hunter R; Shah I; Judson RS
    Toxicol Sci; 2013 Jan; 131(1):40-55. PubMed ID: 23024176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic toxicology data in the evaluation of potential human environmental carcinogens.
    Waters MD; Stack HF; Jackson MA
    Mutat Res; 1999 Jul; 437(1):21-49. PubMed ID: 10425388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.